Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2016
The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?Daan Ja Crommelin, Karl Broich, Chris Holloway, et al.Psychiatry Research|July 27, 2005
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approachAstrid Zobel, Alexius Joe, Nikolaus Freymann, et al.Journal of Alzheimer'S Disease : JAD|August 29, 2016
Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims DataWilly Gomm, Klaus von Holt, Friederike Thomé, et al.International Journal of Molecular Sciences|April 12, 2022
Cav3 T-Type Voltage-Gated Ca2+ Channels and the Amyloidogenic Environment: Pathophysiology and Implications on Pharmacotherapy and PharmacovigilanceAnna Papazoglou, Muhammad Imran Arshaad, Christina Henseler, et al.Journal of the American Geriatrics Society|March 23, 2018
Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance DataHeidi Taipale, Willy Gomm, Karl Broich, et al.Neural Plasticity|January 29, 2016
EEG Radiotelemetry in Small Laboratory Rodents: A Powerful State-of-the Art Approach in Neuropsychiatric, Neurodegenerative, and Epilepsy ResearchAndreas Lundt, Carola Wormuth, Magdalena Elisabeth Siwek, et al.Data in Brief|May 5, 2021
Spontaneous long-term and urethane induced hippocampal EEG power, activity and temperature data from mice lacking the Cav3.2 voltage-gated Ca2+ channelAnna Papazoglou, Muhammad Imran Arshaad, Magdalena Elisabeth Siwek, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 15, 2011
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeuticsManfred Gerlach, Walter Maetzler, Karl Broich, et al.Neural Plasticity|April 30, 2015
Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's diseaseMagdalena Elisabeth Siwek, Ralf Müller, Christina Henseler, et al.Scientific Reports|January 14, 2021
Enhanced hippocampal type II theta activity AND altered theta architecture in mice lacking the Cav3.2 T-type voltage-gated calcium channelMuhammad Imran Arshaad, Magdalena Elisabeth Siwek, Christina Henseler, et al.Pageof 9